A Diagnostic Nomogram for Predicting Vaginal Invasion in Cervical Cancer
ConditionCervix Carcinoma
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-80
SponsorFujian Cancer Hospital
About this trial
This study aims to develop a diagnostic nomogram based on clinical factors with the prediction values of vaginal invasion in cervical cancer to optimize the treatment plan and surgical procedures.
Eligibility criteria
Qualifiers
Pathologically confirmed cervical cancer;
FIGO2018 stage IB-IIA according to the result of physical examination and images;
No preoperative treatment before surgery;
Abdominal MRI is performed within three weeks before surgery. Blood routine, biochemistry, blood tumor markers and coagulation function were examined within 1 week before surgery.
Disqualifiers
Accompanied with other tumors;
Accompanied with chronic infectious and immune diseases;
Incomplete clinical data.
Trial design
Treatments tested in this trial
- no intervention
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov